CRISM Therapeutics Corporation
Develops drug delivery technology for localized chemotherapy in solid tumors.
CRTX | US
Overview
Corporate Details
- ISIN(s):
- VGG042401262
- LEI:
- 213800XFW6MKVCHHPW88
- Country:
- Virgin Islands (British)
- Address:
- C/O MAPLES FINANCE BVI LIMITED, VG1110 ROAD TOWN
- Sector:
- Manufacturing
Description
CRISM Therapeutics Corporation is a pharmaceutical company focused on developing advanced drug delivery technologies. Its flagship product, ChemoSeed®, is an implantable, biodegradable technology designed for the sustained and localized delivery of chemotherapy drugs directly into solid tumors. The primary objective of this approach is to enhance the efficacy of cancer treatments by concentrating therapeutic agents at the tumor site, thereby minimizing systemic toxicity and associated side effects. The company's technology aims to improve the clinical performance of cancer therapies and the bioavailability of poorly soluble compounds, with a mission to provide more effective and better-tolerated treatments to improve patient quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2026-01-09 08:20 |
Results of Shareholder Analysis
|
English | HTML • 15.9 KB | ||
| 2025-12-15 15:40 |
Result of Retail Offer
|
English | HTML • 16.8 KB | ||
| 2025-12-10 09:35 |
Retail Offer
|
English | HTML • 36.4 KB | ||
| 2025-12-10 08:35 |
Placing of £1,000,000
|
English | HTML • 57.2 KB | ||
| 2025-11-27 08:25 |
Holding(s) in Company
|
English | HTML • 22.3 KB | ||
| 2025-10-30 08:00 |
US Orphan Drug Designation Application
|
English | HTML • 16.0 KB | ||
| 2025-10-14 08:00 |
Positive Preclinical Data in Prostate Cancer
|
English | HTML • 17.8 KB | ||
| 2025-09-15 08:00 |
Half Year Report
|
English | HTML • 267.8 KB | ||
| 2025-09-12 08:00 |
Notice of Interim Results and IMC Presentation
|
English | HTML • 14.6 KB | ||
| 2025-09-01 08:00 |
Approval for phase 2 clinical trial
|
English | HTML • 19.0 KB | ||
| 2025-08-26 17:03 |
Result of AGM
|
English | HTML • 25.8 KB | ||
| 2025-08-26 08:00 |
AGM Statement
|
English | HTML • 15.6 KB | ||
| 2025-08-12 08:00 |
GMP Manufacture of ChemoSeed
|
English | HTML • 16.9 KB | ||
| 2025-08-04 18:45 |
Notice of AGM and EMI Option Plan
|
English | HTML • 15.6 KB | ||
| 2025-07-10 16:04 |
Holding(s) in Company
|
English | HTML • 23.3 KB |
Automate Your Workflow. Get a real-time feed of all CRISM Therapeutics Corporation filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CRISM Therapeutics Corporation
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CRISM Therapeutics Corporation via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
